Redhill Biopharma Ltd (RDHL) Price Prediction & ForecastRDHLRedhill Biopharma Ltd

Alphio's RDHL stock price prediction model matches the current Redhill Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.43 (-0.21%). The 1-week path is $0.46 (+6.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Redhill Biopharma Ltd is currently not a strong buy due to its significant financial challenges, including a current price of $0.43 and a forward P/E ratio of 1428.57, indicating extreme valuation concerns. The company has reported a year-to-date change of -58.25%, which reflects its ongoing struggles in the market. While there is potential upside with a projected trajectory of +40.45% based on historical patterns, the risks are substantial, particularly given the negative net income of -2066500.00 USD for both Q1 and Q2 of 2025. Investors should be cautious and consider holding their position rather than buying more at this time.

Redhill Biopharma Ltd (RDHL) last closed at $0.43, gaining +0.94%. These facts feed the 1-day and 1-week RDHL price prediction above.